Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | MIF | P14174 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 9/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SHBG | P04278 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2718720 | 0.87 | SHBG (0.45) | ALDH1A1NR1I2LMNACYP2C9MIF | |
| SCHEMBL4218511 | 0.85 | CNR2 (0.38) | ESR1ESR2 | |
| SCHEMBL2721176 | 0.84 | ALDH1A1 (0.58) | ALDH1A1NR1I2LMNACYP2C9MIF | |
| SCHEMBL4223826 | 0.81 | CYP2C9 (0.37) | ALDH1A1NR1I2LMNACYP2C9MIF | |
| SCHEMBL4218476 | 0.81 | ESR2 (0.47) | CYP2C9ESR1ESR2 | |
| SCHEMBL133971 | 0.78 | ALDH1A1 (0.63) | ALDH1A1NR1I2LMNACYP2C9MIF | |
| SCHEMBL30026979 | 0.78 | ALDH1A1 (0.63) | ALDH1A1NR1I2LMNACYP2C9MIF | |
| SCHEMBL2717708 | 0.76 | ALOX5 (0.48) | ALDH1A1NR1I2LMNACYP2C9MIF | |
| SCHEMBL4217711 | 0.74 | ESR1 (0.43) | ESR1ESR2ARHSP90AA1HSP90AB1 | |
| SCHEMBL4227496 | 0.72 | ALOX5 (0.42) | TYRALOX15HTTESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1995245-B1 | METHOD FOR PRODUCING EPOXY COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2012-05-02 | — | — | EP | disclosed |
| US-20090054669-A1 | Process For Producing Epoxy Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1995245-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054669-A1 | Process For Producing Epoxy Compound | RER1, AR, CYP1A1 | ALDH1A1 464/4885NR1I2 273/4885LMNA 3122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.